Literature DB >> 21159778

Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.

Jonathan L Coloff1, Emily F Mason, Brian J Altman, Valerie A Gerriets, Tingyu Liu, Amanda N Nichols, Yuxing Zhao, Jessica A Wofford, Sarah R Jacobs, Olga Ilkayeva, Sean P Garrison, Gerard P Zambetti, Jeffrey C Rathmell.   

Abstract

The PI3K/Akt pathway is activated in stimulated cells and in many cancers to promote glucose metabolism and prevent cell death. Although inhibition of Akt-mediated cell survival may provide a means to eliminate cancer cells, this survival pathway remains incompletely understood. In particular, unlike anti-apoptotic Bcl-2 family proteins that prevent apoptosis independent of glucose, Akt requires glucose metabolism to inhibit cell death. This glucose dependence may occur in part through metabolic regulation of pro-apoptotic Bcl-2 family proteins. Here, we show that activated Akt relies on glycolysis to inhibit induction of Puma, which was uniquely sensitive to metabolic status among pro-apoptotic Bcl-2 family members and was rapidly up-regulated in glucose-deficient conditions. Importantly, preventing Puma expression was critical for Akt-mediated cell survival, as Puma deficiency protected cells from glucose deprivation and Akt could not readily block Puma-mediated apoptosis. In contrast, the pro-apoptotic Bcl-2 family protein Bim was induced normally even when constitutively active Akt was expressed, yet Akt could provide protection from Bim cytotoxicity. Up-regulation of Puma appeared mediated by decreased availability of mitochondrial metabolites rather than glycolysis itself, as alternative mitochondrial fuels could suppress Puma induction and apoptosis upon glucose deprivation. Metabolic regulation of Puma was mediated through combined p53-dependent transcriptional induction and control of Puma protein stability, with Puma degraded in nutrient-replete conditions and long lived in nutrient deficiency. Together, these data identify a key role for Bcl-2 family proteins in Akt-mediated cell survival that may be critical in normal immunity and in cancer through Akt-dependent stimulation of glycolysis to suppress Puma expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159778      PMCID: PMC3037705          DOI: 10.1074/jbc.M110.179101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 2.  Maintaining the norm: T-cell homeostasis.

Authors:  Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

3.  Akt stimulates aerobic glycolysis in cancer cells.

Authors:  Rebecca L Elstrom; Daniel E Bauer; Monica Buzzai; Robyn Karnauskas; Marian H Harris; David R Plas; Hongming Zhuang; Ryan M Cinalli; Abass Alavi; Charles M Rudin; Craig B Thompson
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

4.  Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation.

Authors:  Subhas C Biswas; Lloyd A Greene
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

5.  BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.

Authors:  Nika N Danial; Colette F Gramm; Luca Scorrano; Chen-Yu Zhang; Stefan Krauss; Ann M Ranger; Sandeep Robert Datta; Michael E Greenberg; Lawrence J Licklider; Bradford B Lowell; Steven P Gygi; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-08-21       Impact factor: 49.962

6.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Authors:  Casey J Fox; Peter S Hammerman; Ryan M Cinalli; Stephen R Master; Lewis A Chodosh; Craig B Thompson
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

7.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance.

Authors:  Jie An; Deborah M Muoio; Masakazu Shiota; Yuka Fujimoto; Gary W Cline; Gerald I Shulman; Timothy R Koves; Robert Stevens; David Millington; Christopher B Newgard
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

8.  Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases.

Authors:  Nathan Majewski; Veronique Nogueira; R Brooks Robey; Nissim Hay
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.

Authors:  Gerry Melino; Francesca Bernassola; Marco Ranalli; Karen Yee; Wei Xing Zong; Marco Corazzari; Richard A Knight; Doug R Green; Craig Thompson; Karen H Vousden
Journal:  J Biol Chem       Date:  2003-11-21       Impact factor: 5.157

10.  Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.

Authors:  Joao T Barata; Ana Silva; Joana G Brandao; Lee M Nadler; Angelo A Cardoso; Vassiliki A Boussiotis
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  52 in total

Review 1.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

2.  Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.

Authors:  Erin M Kropp; Bryndon J Oleson; Katarzyna A Broniowska; Subarna Bhattacharya; Alexandra C Chadwick; Anne R Diers; Qinghui Hu; Daisy Sahoo; Neil Hogg; Kenneth R Boheler; John A Corbett; Rebekah L Gundry
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

3.  Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

Authors:  Jonathan L Coloff; Andrew N Macintyre; Amanda G Nichols; Tingyu Liu; Catherine A Gallo; David R Plas; Jeffrey C Rathmell
Journal:  Cancer Res       Date:  2011-06-13       Impact factor: 12.701

Review 4.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

5.  Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.

Authors:  Shihao Xu; Cody M Spencer; Joshua Munger
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 6.  Metabolic pathways in T cell fate and function.

Authors:  Valerie A Gerriets; Jeffrey C Rathmell
Journal:  Trends Immunol       Date:  2012-02-17       Impact factor: 16.687

Review 7.  Matched and mismatched metabolic fuels in lymphocyte function.

Authors:  Alfredo Caro-Maldonado; Valerie A Gerriets; Jeffrey C Rathmell
Journal:  Semin Immunol       Date:  2013-01-03       Impact factor: 11.130

Review 8.  Metabolic regulation of T lymphocytes.

Authors:  Nancie J MacIver; Ryan D Michalek; Jeffrey C Rathmell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 9.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

10.  Metabolism and autophagy in the immune system: immunometabolism comes of age.

Authors:  Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.